'Familial hypercholesterolemia' presentation slideshows

Patterns of Single-Gene Inheritance

Patterns of Single-Gene Inheritance. Lecture 3. Autosomal Dominant Inheritance. More than half of all mendelian disorders are inherited as AD traits.

1.25k views • 122 slides

Primary hyperlipidemias

Primary hyperlipidemias. Dr Shreetal Rajan , Senior Resident, Cardiology,MCH,Calicut. Primary hyperlipidemias. Classification of hyperlipidemias Overview on lipid metabolism Primary hyperlipidemias Management. Terminology. Hyperlipidemia

877 views • 72 slides

Introduction into clinical medicine

583 views • 44 slides

Genetics of Lipoprotein Disorders

Genetics of Lipoprotein Disorders. Jacques Genest MD Cardiovascular Genetics Laboratory McGill University Health Center. Epidemiology and Lipoprotein Metabolism Genetics of Lipoprotein Disorders Disorders of HDL; Diagnosis and Treatment.

1.07k views • 42 slides

The Nutrition Prevention and Reversal of Cardiovascular Disease: Fact or Fiction?

367 views • 36 slides

23 Year Old Female of Child Bearing Age with Familial Hypercholesterolemia

23 Year Old Female of Child Bearing Age with Familial Hypercholesterolemia. C ase category: Primary Prevention, Familial Hypercholesterolemia, Child Bearing Age

347 views • 34 slides

Apheresis

Apheresis. Matthew L. Paden, MD Assistant Professor of Pediatric Critical Care Director, Pediatric ECMO. Disclosures. Funded by NIH/FDA for CRRT/ECMO device development Pending grant for pediatric apheresis device Much of this talk is stolen from others. Objectives.

2.55k views • 27 slides

Familial Hypercholesterolemia: Background Information

Familial Hypercholesterolemia: Background Information. Clinical Assistant Professor of Medicine NYU School of Medicine NYU Langone Center for Cardiovascular Disease Prevention Director, Bellevue Hospital Lipid Clinic, New York,NY. James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA.

546 views • 27 slides

Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies

Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies. Statin Intolerance. PROVE-IT TIMI 22. Familial Hypercholesterolemia. Estimated Rates of FH Diagnoses. LDL Hypothesis. Impact of PCSK9 on LDL Receptor Expression. PCSK9 Inhibitors. Abbreviations. Abbreviations (cont).

336 views • 18 slides

Scenario

Scenario

228 views • 15 slides

Scenario

Scenario

219 views • 15 slides

Autosomal Dominance

723 views • 7 slides